Altfest L J & CO Inc Global Blood Therapeutics, Inc. Transaction History

Altfest L J & CO Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 28, 2021	SELL	$32.46 - $43.42 $281,200 - $376,147	-8,663 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$38.94 - $50.85 $5,334 - $6,966	137 Added 1.61%	8,663 $353,000
Q4 2020 Jan 21, 2021	BUY	$37.65 - $63.77 $165,170 - $279,758	4,387 Added 105.99%	8,526 $369,000
Q3 2020 Oct 29, 2020	BUY	$52.76 - $74.49 $43,157 - $60,932	818 Added 24.63%	4,139 $228,000
Q2 2020 Jul 21, 2020	BUY	$48.73 - $81.82 $161,832 - $271,724	3,321 New	3,321 $210,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Altfest L J & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Altfest L J & CO Inc with notifications on news.